New strategies in insulin treatment: analogues and noninvasive routes of administration.
Abstract Recent years have seen the development of alternatives to human insulin for the treatment of diabetes. Both rapid-acting and long-acting analogues are available. Alternative routes of insulin administration are emerging. The present review briefly summarizes the present knowledge on insulin analogues and alternative administration routes.
Rungby
Jørgen
J
Department of Clinical Pharmacology and Departments of Endocrinology C & M, Aarhus University Hospital, Bartholin Bldn., University of Aarhus, DK-8000 Aarhus C, Denmark. jr@farm.au.dk
Brock
Birgitte
B
Schmitz
Ole
O
D000280:Administration, Inhalation; D003920:Diabetes Mellitus / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D007328:Insulin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000069036:Insulin Glargine; D061268:Insulin Lispro; D049528:Insulin, Long-Acting
D007004:Hypoglycemic Agents; D007328:Insulin; D061268:Insulin Lispro; D049528:Insulin, Long-Acting; D000069036:Insulin Glargine